Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,634 | 901 | 97.7% |
| Education | $431.42 | 6 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,287 | 204 | $0 (2024) |
| Janssen Biotech, Inc. | $2,065 | 106 | $0 (2024) |
| LEO Pharma Inc. | $1,181 | 73 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,113 | 37 | $0 (2024) |
| Lilly USA, LLC | $1,056 | 51 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,048 | 49 | $0 (2024) |
| GENZYME CORPORATION | $937.82 | 29 | $0 (2024) |
| Incyte Corporation | $864.85 | 35 | $0 (2024) |
| Galderma Laboratories, L.P. | $749.40 | 34 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $704.90 | 39 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,384 | 193 | ABBVIE INC. ($810.39) |
| 2023 | $3,692 | 176 | ABBVIE INC. ($693.36) |
| 2022 | $3,296 | 180 | ABBVIE INC. ($613.13) |
| 2021 | $1,400 | 82 | AbbVie Inc. ($357.85) |
| 2020 | $515.85 | 24 | Janssen Biotech, Inc. ($109.74) |
| 2019 | $1,686 | 71 | EPI Health, LLC ($305.93) |
| 2018 | $1,830 | 87 | Ortho Dermatologics, a division of Bausch Health US, LLC ($323.12) |
| 2017 | $2,263 | 94 | Aqua Pharmaceuticals ($464.53) |
All Payment Transactions
907 individual payment records from CMS Open Payments — Page 2 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.44 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: Dermatology | ||||||
| 10/28/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.89 | General |
| Category: Immunology | ||||||
| 10/25/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $112.79 | General |
| Category: Dermatology | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $101.70 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $43.49 | General |
| Category: Immunology | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Dermatology | ||||||
| 10/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Immunology | ||||||
| 10/18/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $10.81 | General |
| Category: Dermatology | ||||||
| 10/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.23 | General |
| Category: Immunology | ||||||
| 10/17/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Inflammation | ||||||
| 10/16/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: DERMATOLOGY | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $31.21 | General |
| Category: Immunology | ||||||
| 10/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $29.59 | General |
| Category: Immunology | ||||||
| 10/07/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $34.42 | General |
| Category: Immunology | ||||||
| 10/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Immunology | ||||||
| 10/04/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: DERMATOLOGY | ||||||
| 10/01/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $40.14 | General |
| Category: Immunology | ||||||
| 09/30/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.50 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,982 | 3,638 | $492,291 | $162,967 |
| 2022 | 20 | 1,788 | 3,368 | $509,616 | $170,589 |
| 2021 | 18 | 1,547 | 2,921 | $355,041 | $146,054 |
| 2020 | 18 | 1,358 | 2,472 | $225,460 | $103,217 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 504 | 682 | $136,128 | $45,445 | 33.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 199 | 252 | $66,692 | $23,123 | 34.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 237 | 237 | $58,372 | $17,548 | 30.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 223 | 313 | $48,082 | $14,023 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 119 | $33,493 | $11,465 | 34.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 60 | 83 | $32,268 | $11,450 | 35.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 136 | 142 | $33,473 | $10,952 | 32.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 167 | 1,147 | $17,962 | $6,554 | 36.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 110 | 125 | $15,785 | $5,426 | 34.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 78 | 78 | $12,573 | $3,922 | 31.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 12 | 12 | $8,403 | $3,273 | 39.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $6,924 | $2,141 | 30.9% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 13 | 17 | $5,217 | $1,782 | 34.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 26 | 40 | $4,654 | $1,734 | 37.3% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 16 | 16 | $4,587 | $1,680 | 36.6% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 31 | 34 | $4,435 | $1,300 | 29.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 35 | 86 | $2,732 | $959.98 | 35.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 53 | 236 | $513.48 | $188.88 | 36.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 443 | 701 | $141,495 | $47,511 | 33.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 192 | 252 | $66,931 | $23,479 | 35.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 242 | 242 | $60,156 | $18,767 | 31.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 90 | 128 | $36,431 | $13,181 | 36.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 128 | 139 | $33,391 | $11,100 | 33.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 158 | 231 | $35,637 | $10,655 | 29.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 44 | 65 | $25,422 | $9,350 | 36.8% |
About Dr. Daniel Navi, M.D
Dr. Daniel Navi, M.D is a Dermatology healthcare provider based in Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2007. The National Provider Identifier (NPI) number assigned to this provider is 1215121280.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Navi, M.D has received a total of $19,065 in payments from pharmaceutical and medical device companies, with $4,384 received in 2024. These payments were reported across 907 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($18,634).
As a Medicare-enrolled provider, Navi has provided services to 6,675 Medicare beneficiaries, totaling 12,399 services with total Medicare billing of $582,828. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Palo Alto, CA
- Active Since 08/31/2007
- Last Updated 03/02/2017
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1215121280
Products in Payments
- DUPIXENT (Biological) $1,927
- SKYRIZI (Biological) $1,603
- TREMFYA (Drug) $1,554
- TALTZ (Drug) $1,029
- OPZELURA (Drug) $864.85
- ADBRY (Biological) $732.59
- RINVOQ (Biological) $697.78
- ILUMYA (Biological) $559.11
- Humira (Biological) $536.83
- COSENTYX (Biological) $492.34
- EUCRISA (Drug) $476.46
- ENSTILAR (Drug) $443.44
- XTRAC (Device) $443.01
- Sotyktu (Drug) $358.03
- Sitavig (Drug) $348.90
- Cimzia (Drug) $337.58
- REMICADE (Biological) $309.60
- SILIQ (Drug) $307.94
- Otezla (Drug) $306.57
- HUMIRA (Biological) $238.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Palo Alto
John Doux, M.d, M.D
Dermatology — Payments: $124,944
Joyce Teng, Md, MD
Dermatology — Payments: $115,109
Shireen Guide, Md, MD
Dermatology — Payments: $79,371
Ilka Netravali, Md, MD
Dermatology — Payments: $28,025
Dr. Thomas Hoffman, M.d, M.D
Dermatology — Payments: $17,860
Dr. Miguel Canales, M.d, M.D
Dermatology — Payments: $8,023